Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan C Moss

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|November 5, 2013
Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypesParham Safaie, Maggie Ham, Peter Kuang, et al.
Inflammatory Bowel Diseases|August 20, 2016
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's DiseaseByron P Vaughn, Tommi Vatanen, Jessica R Allegretti, et al.
Biochemical and Biophysical Research Communications|May 9, 2006
ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasionAlan C Moss, Garrett Lawlor, David Murray, et al.
Nuclear Medicine Communications|July 31, 2014
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scansElisa Franquet, Mathew R Palmer, Anne E Gifford, et al.
Inflammatory Bowel Diseases|March 1, 2013
Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remissionLaura Rosenberg, Garrett O Lawlor, Talia Zenlea, et al.
The American Journal of Gastroenterology|March 16, 2016
Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective StudyTalia Zenlea, Eric U Yee, Laura Rosenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2013
Histologic markers of inflammation in patients with ulcerative colitis in clinical remissionLaura Rosenberg, Kavinderjit S Nanda, Talia Zenlea, et al.
European Journal of Immunology|September 12, 2012
CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel diseaseGlen A Doherty, Aiping Bai, Dusan Hanidziar, et al.
Gut|April 7, 2007
Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alphaAlan C Moss, Pauline Anton, Tor Savidge, et al.
Journal of Crohn'S & Colitis|November 7, 2019
Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's DiseaseRené J Robles, Samiran Mukherjee, Marta Vuerich, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|November 5, 2013
Lectin-reactive anti-α-gal in patients with Crohn's disease: correlation with clinical phenotypesParham Safaie, Maggie Ham, Peter Kuang, et al.
Inflammatory Bowel Diseases|August 20, 2016
Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's DiseaseByron P Vaughn, Tommi Vatanen, Jessica R Allegretti, et al.
Biochemical and Biophysical Research Communications|May 9, 2006
ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasionAlan C Moss, Garrett Lawlor, David Murray, et al.
Nuclear Medicine Communications|July 31, 2014
Rifaximin suppresses background intestinal 18F-FDG uptake on PET/CT scansElisa Franquet, Mathew R Palmer, Anne E Gifford, et al.
Inflammatory Bowel Diseases|March 1, 2013
Predictors of endoscopic inflammation in patients with ulcerative colitis in clinical remissionLaura Rosenberg, Garrett O Lawlor, Talia Zenlea, et al.
The American Journal of Gastroenterology|March 16, 2016
Histology Grade Is Independently Associated With Relapse Risk in Patients With Ulcerative Colitis in Clinical Remission: A Prospective StudyTalia Zenlea, Eric U Yee, Laura Rosenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2013
Histologic markers of inflammation in patients with ulcerative colitis in clinical remissionLaura Rosenberg, Kavinderjit S Nanda, Talia Zenlea, et al.
European Journal of Immunology|September 12, 2012
CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel diseaseGlen A Doherty, Aiping Bai, Dusan Hanidziar, et al.
Gut|April 7, 2007
Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alphaAlan C Moss, Pauline Anton, Tor Savidge, et al.
Journal of Crohn'S & Colitis|November 7, 2019
Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's DiseaseRené J Robles, Samiran Mukherjee, Marta Vuerich, et al.
Pageof 14